Reply
We appreciate the important information presented by Dr. Ntim and colleagues in reference to our report on diastolic dysfunction in sickle cell disease (SCD) patients. They suggest that renal insufficiency in our cohort may have been underestimated by using absolute serum creatinine levels instead of creatinine clearance. We have found in our sickle cell patient cohort that absolute creatinine levels correlate well with estimated creatinine clearance using the Modification of Diet in Renal Disease (MDRD) study equation and Cockgroft-Galt (CG) formulas (Spearman ϭ Ϫ0.91, p Ͻ 0.0001 and ϭ Ϫ0.71, p Ͻ 0.0001, respectively). Indeed, renal disease characterized by any of these measures is an important risk factor in the SCD population, and we reported in our initial study (1) that, "besides the tricuspid regurgitant jet velocity, the only significant univariate correlate of the risk of death was the creatinine level (p ϭ 0.007)." In the present study (2), we found a good correlation between the creatinine level and the E/A ratio ( ϭ Ϫ0.46; p Ͻ 0.0001); however, the E/A ratio remained significantly associated with mortality after adjustment for log 10 creatinine. Similarly, when we adjusted for the MDRD GFR and CG GFR, the E/A ratio remained significantly associated with mortality (p ϭ 0.0001 and p ϭ 0.0002, respectively).
Although our study shows evidence of diastolic dysfunction in the SCD population, the etiology of this is likely to be multifactorial and may include relative systemic hypertension, microvascular vaso-occlusive disease, and iron overload. The presence of iron in the myocardium can be detected by advanced imaging techniques, including tissue Doppler echocardiography (3) and magnetic resonance imaging (4). We certainly agree that more accurate population-based measures of iron burden would be of great value to this field of research.
